HEMOBLAST Bellows
FDA premarket approval P170012/S026 · decided 2021-10-28
Approval details
- PMA number
- P170012
- Supplement
- S026
- Supplement type
- 135 Review Track For 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- HEMOBLAST Bellows
- Generic name
- Absorbable collagen hemostatic agent with thrombin
- Applicant
- Dilon Technologies, Inc.
- Date received
- 2021-03-29
- Decision date
- 2021-10-28
- Days to decision
- 213 days
- Decision code
- APPR
- Product code
- PMX
- Advisory committee
- General, Plastic Surgery
- Expedited review
- No
- Location
- Newport News, VA
- Statement
- Approval for modifications to the production equipment used in the Basic Fibrous Collagen (FB05) manufacturing process for the manufacture of HEMOBLAST Bellows Hemostatic Powder.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| DILON 6800 ACELLA (ACELLA) (K110384) | Dilon Technologies, Inc. | 2011-05-03 |
| DILON 2000, MODEL 2000-6X8 AND DILON 2000, MODEL 2000-5X5 (K984466) | Dilon Technologies, Inc. | 1999-03-16 |